Healthcare provider profile · identity verified

Daniel Stevenson Stadler, MD

Internal Medicine · SKOWHEGAN, ME · NPI 1467479022

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	444	52
Eliquis	Apixaban	423	46
Atorvastatin Calcium	Atorvastatin Calcium	419	89
Sertraline Hcl	Sertraline Hcl	281	56
Tamsulosin Hcl	Tamsulosin Hcl	231	20
Mirtazapine	Mirtazapine	226	59
Gabapentin	Gabapentin	221	43
Amlodipine Besylate	Amlodipine Besylate	211	36
Trazodone Hcl	Trazodone Hcl	206	47
Metformin Hcl	Metformin Hcl	191	40
Lisinopril	Lisinopril	188	32
Januvia	Sitagliptin Phosphate	181	22
Duloxetine Hcl	Duloxetine Hcl	177	31
Metoprolol Tartrate	Metoprolol Tartrate	167	35
Finasteride	Finasteride	156	11
Citalopram Hbr	Citalopram Hydrobromide	152	22
Furosemide	Furosemide	150	30
Carbidopa-Levodopa	Carbidopa/Levodopa	141	19
Quetiapine Fumarate	Quetiapine Fumarate	134	30
Jardiance	Empagliflozin	123	12
Losartan Potassium	Losartan Potassium	118	29
Olanzapine	Olanzapine	118	20
Omeprazole	Omeprazole	115	26
Risperidone	Risperidone	110	27
Metoprolol Succinate	Metoprolol Succinate	109	25
Pantoprazole Sodium	Pantoprazole Sodium	102	25
Buspirone Hcl	Buspirone Hcl	90	17
Divalproex Sodium	Divalproex Sodium	76	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	70	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	14
Hydrochlorothiazide	Hydrochlorothiazide	65	13
Potassium Chloride	Potassium Chloride	65	22
Spironolactone	Spironolactone	58	11
Latanoprost	Latanoprost	56	12
Levetiracetam	Levetiracetam	56	12
Baclofen	Baclofen	55	11
Rivastigmine	Rivastigmine Tartrate	55	suppressed
Bupropion Hcl	Bupropion Hcl	52	suppressed
Prednisone	Prednisone	52	24
Clopidogrel	Clopidogrel Bisulfate	45	suppressed
Cephalexin	Cephalexin	42	18
Donepezil Hcl	Donepezil Hcl	41	15
Lamotrigine	Lamotrigine	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	41	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	40	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Simvastatin	Simvastatin	35	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	34	suppressed
Timolol Maleate	Timolol Maleate	33	suppressed
Tradjenta	Linagliptin	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Ondansetron Odt	Ondansetron	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Nystatin	Nystatin	30	18
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Glipizide	Glipizide	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	17
Trulicity	Dulaglutide	28	suppressed
Vascepa	Icosapent Ethyl	28	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	12
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Lorazepam	Lorazepam	25	18
Albuterol Sulfate Hfa	Albuterol Sulfate	24	12
Haloperidol	Haloperidol	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Atenolol	Atenolol	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Famotidine	Famotidine	23	12
Lansoprazole	Lansoprazole	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Dantrolene Sodium	Dantrolene Sodium	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Carvedilol	Carvedilol	19	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	suppressed
Bydureon Bcise	Exenatide Microspheres	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	12
Humalog	Insulin Lispro	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Methimazole	Methimazole	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Digoxin	Digoxin	17	suppressed
Entacapone	Entacapone	17	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Klor-Con 10	Potassium Chloride	16	suppressed
Lithium Carbonate	Lithium Carbonate	16	suppressed
Ozempic	Semaglutide	16	suppressed
Sodium Chloride	0.9 % Sodium Chloride	16	12
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Budesonide	Budesonide	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Clozapine	Clozapine	14	suppressed
Cyclosporine	Cyclosporine	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	14	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	14	suppressed
Mycophenolic Acid	Mycophenolate Sodium	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Lactulose	Lactulose	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	13
Oxcarbazepine	Oxcarbazepine	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Dexilant	Dexlansoprazole	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Torsemide	Torsemide	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error